
Eroboghene Ubogu
Division Director, Neuromuscular · University of Alabama Hospital
Credentials: · · · · · · ·
History
- 2006–2007
Neuromuscular Medicine
- 2003–2004
Clinical Neurophysiology

Research
The expression and function of chemokines involved in CNS inflammation
Review · Trends in Pharmacological Sciences · 2006 · First of 3 authors · 215 citations
Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis
Brain · 2006 · 177 citations
Inflammatory cell migration into the central nervous system: a few new twists on an old tale
Review · Brain Pathology · 2007 · 175 citations

10 papers · 5 as a fellow

6 papers

3 papers · 1 as a fellow

3 papers · 1 as a fellow

2 papers

2 papers

2 papers · 1 as a fellow

2 papers
Grants
- 2020–2023
Alpha-1 Catenin Regulation of the Mammalian Blood-Nerve Barrier
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $408.4K · University of Alabama at Birmingham
- 2019–2021
CD11d Antagonism for Chronic Inflammatory Neuropathies
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $408.4K · University of Alabama at Birmingham
- 2012–2018
Vascular Biology of the Human Blood-Nerve Barrier
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.6M · University of Alabama at Birmingham
- 2012–2015
Alpha M Beta 2 Integrin Blockade for Acute Inflammatory Neuropathies
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $423.5K · University of Alabama at Birmingham

